Cymat Technologies Ltd. CYMHF
$0.10
$0.0221.72%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -47.81% | -65.10% | -36.58% | -27.87% | 121.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.81% | -65.10% | -36.58% | -27.87% | 121.42% |
| Cost of Revenue | -39.93% | -43.88% | -24.55% | -10.87% | 54.70% |
| Gross Profit | -98.74% | -135.63% | -106.28% | -276.29% | 223.89% |
| SG&A Expenses | 4.68% | 7.23% | -3.28% | -15.72% | -20.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.06% | -19.71% | -13.61% | -14.54% | 9.39% |
| Operating Income | -22.27% | -62.86% | -10.37% | 3.38% | 38.25% |
| Income Before Tax | -47.45% | -53.73% | -17.64% | -7.05% | 23.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.45% | -53.73% | -17.64% | -7.05% | 23.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.45% | -53.73% | -17.64% | -7.05% | 23.21% |
| EBIT | -22.27% | -62.86% | -10.37% | 3.38% | 38.25% |
| EBITDA | -29.38% | -82.44% | -18.36% | -2.82% | 40.49% |
| EPS Basic | -5.35% | -29.41% | -7.45% | -1.43% | 25.05% |
| Normalized Basic EPS | -2.52% | -30.20% | -8.51% | -2.28% | 23.72% |
| EPS Diluted | -5.35% | -29.41% | -7.45% | -1.43% | 25.05% |
| Normalized Diluted EPS | -2.52% | -30.20% | -8.51% | -2.28% | 23.72% |
| Average Basic Shares Outstanding | 39.72% | 23.64% | 11.15% | 5.09% | 2.43% |
| Average Diluted Shares Outstanding | 39.72% | 23.64% | 11.15% | 5.09% | 2.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |